| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 238.71B | 255.69B | 236.33B | 223.20B | 212.36B | 208.08B |
| Gross Profit | 93.91B | 101.46B | 92.89B | 87.31B | 84.44B | 86.03B |
| EBITDA | 22.14B | 26.23B | 22.01B | 20.13B | 20.16B | 25.27B |
| Net Income | 11.34B | 14.70B | 11.22B | 9.82B | 10.25B | 14.30B |
Balance Sheet | ||||||
| Total Assets | 138.49B | 128.68B | 142.95B | 133.77B | 127.94B | 122.70B |
| Cash, Cash Equivalents and Short-Term Investments | 58.80B | 42.08B | 62.15B | 58.19B | 58.08B | 58.25B |
| Total Debt | 1.28B | 870.00M | 1.43B | 1.78B | 1.90B | 1.98B |
| Total Liabilities | 30.32B | 35.84B | 34.94B | 31.73B | 30.49B | 30.24B |
| Stockholders Equity | 108.17B | 92.84B | 108.00B | 102.04B | 97.45B | 92.46B |
Cash Flow | ||||||
| Free Cash Flow | 3.27B | 11.71B | 10.93B | 7.08B | 6.74B | 13.41B |
| Operating Cash Flow | 4.60B | 19.02B | 16.00B | 12.23B | 11.34B | 17.65B |
| Investing Cash Flow | -4.73B | -4.47B | -12.28B | -6.19B | -6.61B | -2.34B |
| Financing Cash Flow | -1.48B | -30.52B | -5.92B | -5.94B | -5.95B | -7.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥110.27B | 10.45 | ― | 1.92% | 2.00% | 9.17% | |
71 Outperform | ¥272.37B | 17.16 | 12.03% | 1.96% | 8.20% | 51.62% | |
69 Neutral | ¥219.15B | 19.90 | ― | 2.43% | 3.62% | 11.01% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥2.72T | 23.93 | 16.37% | 0.73% | 7.63% | 17.33% | |
61 Neutral | ¥23.83B | 17.60 | ― | 2.89% | 8.14% | 9.49% | |
55 Neutral | ¥52.36B | -52.70 | ― | 0.51% | 4.41% | ― |